American consumer packaged goods and pharmaceutical group Johnson & Johnson has appointed Chris DelOrefice to the position of vice president of investor relations.
DelOrefice will report to Joseph Wolk, executive vice president and CFO.
DelOrefice has been with Johnson & Johnson for 19 years, most recently serving as CFO of the North American hospital medical devices business.
Previously, he held leadership roles across all three segments of Johnson & Johnson: consumer, pharmaceutical and medical devices.
‘Chris is an accomplished leader, with a long track record of success. He consistently demonstrates Credo values [company values developed in 1943] and will continue to have a positive impact on Johnson & Johnson’s financial strength and stability and on the development of our future business leaders,’ Wolk says in a statement.
